Steven Daveluy is a Dermatology physician affiliated with Wayne State University. OpenAlex indexes 179 publications with 1,723 citations (h-index 19); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
18100 Oakwood Blvd
Suite 300
Dearborn, MI 481244085
Telephone
313-240-4900Provider last certified this registry record 7 Dec 2023.
Clinical trials
- Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae
Sponsor: Wayne State University
- Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris
Sponsor: Wayne State University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
50 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year202567 payments$55,342openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year202518 payments$17,656openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year202520 payments$11,877openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
38.8%Corticosteroid26.4%Triamcinolone Acetonide70%Triamcinolone acetonide30%Part D + Part B≥57 patientsalpha-Hydroxy Acid5.4%Ammonium Lactate100%Part D≥24 patients+ 2 more classes in this area
Sensory organs
30.8%Corticosteroid30.8%Clobetasol Propionate75%Hydrocortisone15%Betamethasone Dipropionate10%Part D<11 patientsAnti-infectives
19.2%Azole Antifungal13.3%Ketoconazole100%Part D≥30 patientsLincosamide Antibacterial3.5%Clindamycin Phosphate100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Postmarketing safety surveillance of adalimumab, secukinumab, and infliximab in hidradenitis suppurativa: an analysis of the FDA adverse events reporting system (FAERS) database
Journal of the American Academy of Dermatology
2025 - Photoacoustic imaging for cutaneous melanoma assessment: a comprehensive review
Journal of Biomedical Optics
2024 - Quality of life and the patient journey in hidradenitis suppurativa
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Sonia Hassan, MD
Wayne State University
Tinnakorn Chaiworapongsa, MD
Wayne State University
Robert Sokol, MD
Wayne State University
Robert Lisak, MD
Wayne State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”